Advertisement

Topics

CardioMend Company Profile

20:13 EST 18th November 2017 | BioPortfolio

CardioMend’s heart valve technology is designed to avoid the problems associated with current replacement heart valves, whether mechanical, animal tissue, or human cadaver tissue. Mechanical valves, while durable, require patients to be on lifelong daily anti-coagulation (blood thinning) medication to reduce the risk of blood clotting that might otherwise occur. Animal and cadaver tissue valves usually reduce or eliminate the need for patients to take anti-coagulation medication, but their durability is limited, often because of calcific degeneration or calcium build-up on the foreign tissue leaflets. An immune response to the foreign tissue has been implicated in the limited durability of commercially available tissue valves, which are unsuitable for use in younger patient cohorts, including infants and children.For these reasons, surgeons have begun to favor repair and reconstruction of mitral valves when that option is available. Mitral valve repair can include extension of a valve leaflet with the use of autologous (the patient’s own) pericardial tissue, which has been shown to avoid immunogenic response that could lead to calcific degeneration. But surgeons have not had products or a procedure that would allow them to consistently reconstruct aortic valves using autologous pericardium. Though the concept of reconstructing aortic valves with autologous tissue is not new, it has only been practiced successfully by a few pioneering surgeons using their own freehand techniques.
For the last several years, CardioMend has been dedicated to developing technology that would allow simple, consistent, and reproducible semilunar (aortic and pulmonary) valve reconstruction using autologous pericardium without the need for an implantable device. CardioMend will continue its product development efforts by applying the same reconstruction principles to the atrioventricular (mitral and tricuspid) valves.

Location

48 Whitehall Avenue
Mystic
Connecticut
06355
United States of America

Contact

Phone: 860-572-8531
Email: info@cardiomend.com.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

CardioMend

CardioMend’s heart valve technology is designed to avoid the problems associated with current replacement heart valves, whether mechanical, animal tissue, or human cadaver tissue. Mechanical valves...

More Information about "CardioMend" on BioPortfolio

We have published hundreds of CardioMend news stories on BioPortfolio along with dozens of CardioMend Clinical Trials and PubMed Articles about CardioMend for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CardioMend Companies in our database. You can also find out about relevant CardioMend Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record